Skip to content

Drug interactions

Aprepitant + Olaparib

Severity: Major

Aprepitant and Olaparib: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Aprepitant is a moderate CYP3A4 inhibitor and can raise olaparib plasma concentrations. Higher exposure may increase olaparib toxicities such as anemia, nausea and fatigue.

What this interaction means in plain words

Aprepitant and Olaparib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Aprepitant belongs to Gastrointestinal Tract; Olaparib belongs to Oncology.

Evidence level: Moderate

Why it happens

Aprepitant inhibits CYP3A4-mediated metabolism of olaparib, increasing its exposure.

What to do

Avoid the combination if possible; if it is required, reduce the olaparib dose as stated in its labeling for moderate CYP3A inhibitors. Monitor for hematologic toxicity and GI effects.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Aprepitant and Olaparib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Aprepitant with Olaparib?

MediHelp rates the interaction as major. Aprepitant and Olaparib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Aprepitant is a moderate CYP3A4 inhibitor and can raise olaparib plasma concentrations. Higher exposure may increase olaparib toxicities such as anemia, nausea and fatigue.

How serious is the interaction between Aprepitant and Olaparib?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination if possible; if it is required, reduce the olaparib dose as stated in its labeling for moderate CYP3A inhibitors. Monitor for hematologic toxicity and GI effects.

What other medicines interact with Aprepitant?

MediHelp also lists interactions of Aprepitant with, for example, Lomitapide, Pimozide, Avapritinib. The full list is on the Aprepitant page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in